The Fertility Test Market was valued at USD 7.14 billion in 2024 and is estimated at USD 7.69 billion in 2025, with a projected value of USD 15.22 billion by 2034. The market is expected to grow at a CAGR of 7.88% from 2025 to 2034, with 2024 as the base year. Growing rates of infertility fueled by lifestyle factors and late pregnancies, along with increasing reproductive health awareness and early diagnosis, are driving growth.

Rising Infertility Shapes Demand

Rising infertility linked to stress, unhealthy diet, and postponement of childbearing is propelling demand for fertility test solutions. People seeking timely information to conceive are adopting both home and clinical testing. The World Health Organization has published that around 17.5% of the adult population, roughly one in six individuals, experiences infertility in their lifetime.

Awareness Campaigns and Early Diagnosis

Increasing public reproductive health awareness and understanding of the advantages of early diagnosis are motivating consumers to use testing solutions. Awareness campaigns, healthcare guidance, and digital platforms are promoting proactive fertility monitoring. In China, government campaigns encouraging reproductive health knowledge increase test uptake, and the U.S. benefits from strong awareness programs alongside advanced home and clinical testing solutions.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/fertility-test-market

Clinical Demand and Digital Technology

Hospitals and fertility centers are projected to register the highest growth rate by end user, owing to growing demand for clinical-grade fertility diagnostics. Alliances with diagnostic firms and the integration of advanced lab-based testing solutions are also driving institutional adoption. Key players are introducing AI-based and digital-integrated solutions to improve accuracy, user experience, and personalized suggestions, and technological innovation in digital and AI-enabled fertility monitoring is creating new market prospects. In October 2025, Valley Health opened a new fertility clinic in Winchester to offer extensive reproductive care.

E-Commerce and Market Access

Growing e-commerce channels, collaboration with fertility clinics, and developing markets are opening new prospects for manufacturers. The U.S. Census Bureau announced that retail e-commerce sales were USD 304.2 billion in Q2 2025, a 1.4% growth from the previous quarter on a seasonally adjusted basis. Online products are expected to expand at the highest CAGR among purchase modes because online buying is convenient, affordable, and easier to track digitally. However, the high cost of testing and limited insurance reimbursement continue to be major hurdles.

Regional Insights

North America led the market, and the U.S. dominated the region because of high infertility rates and strong awareness programs. Europe holds a substantial share, with high demand for clinical fertility tests and a rising female workforce delaying childbirth. Asia Pacific is the fastest-growing region, driven by increasing urban infertility prevalence, and a study by the Indian Society of Assisted Reproduction found that about 10–14% of India’s population experiences infertility. China dominated Asia Pacific amid evolving family planning patterns.

Segment Highlights

By application, female fertility testing dominated in 2024 on demand for ovulation and hormonal evaluation solutions. By mode of purchase, direct/prescription products led in 2024 owing to clinical reliability and advice from healthcare providers, and by end user, home care settings led owing to the desire for privacy and convenience.

In North America, the Sexual and Reproductive Health Fund was initiated in 2021 with USD 32.02 million to enhance access to healthcare among under-served populations. Additional funding of USD 25.62 million in 2023 took overall funding up to USD 57.64 million by 2027. In Europe, the growing preference for personalized reproductive health solutions also drives regional growth.

Key Players in the Fertility Test Market

Some of the major players operating in the global market include:

•       Abbott Laboratories

•       Babystart Ltd

•       Church & Dwight Co., Inc.

•       Fairhaven Health LLC

•       Fertility Focus Limited

•       Geratherm Medical AG

•       HiLin Life Products

•       Laboratory Corporation of America Holdings

•       Prestige Brands Holdings Inc.

•       Quidel Corporation

•       Swiss Precision Diagnostics GmbH

•       UEBE Medical GmbH

Conclusion

The Fertility Test Market is supported by rising infertility, growing awareness, and expanding access through both clinical and online routes. Cost and reimbursement remain hurdles, yet digital innovation and institutional demand offer clear opportunities. B2B stakeholders that balance clinical-grade offerings with convenient digital access are well placed as the market grows toward USD 15.22 billion by 2034 at a CAGR of 7.88%.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market